FdaApplication
NDA 050718
Identifiers
- fda_app_no: NDA050718
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1995-11-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXIL (LIPOSOMAL) | DOXORUBICIN HYDROCHLORIDE | 50MG/25ML (2MG/ML) | INJECTABLE, LIPOSOMAL;INJECTION |
| DOXIL (LIPOSOMAL) | DOXORUBICIN HYDROCHLORIDE | 20MG/10ML (2MG/ML) | INJECTABLE, LIPOSOMAL;INJECTION |
2 products